#hepacivirus
"The postdoc had to leave the lab after four years without a single intact publication to show for her work on hepacivirus."

The frequency that postdocs are put in shitty positions...😮‍💨
September 6, 2025 at 1:35 PM
As part of our 2025 “Rising Stars in #Vaccinology and #Immunity to #Microbes” seminar series, we spoke with Dr. John Gridley who uses a rat #hepacivirus infection model to investigate the generation of protective immune responses during #HCV infection. cvimp.podbean.com/e/episode-17...
Episode 17: Using a rodent hepacivirus to uncover a role for iHALT during HCV infection | Creating Memory: Vaccines & Immunity
We talk with Dr. John Gridley, a postdoctoral fellow in the Vaccinology Training Program at Emory University, GA, who uses a hepatitis C virus-related rodent hepacivirus model to identify correlates o...
cvimp.podbean.com
October 28, 2025 at 2:25 AM
Looking forward to learn more about virology at the UK Hepacivirus and Flavivirus Meeting in the beautiful Rydal Hall in the Lake District 🦠☀️🕶️
May 17, 2025 at 10:14 AM
Check out our recent paper, showing how Norway rat hepacivirus (NrHV) continuously escapes neutralizing antibodies. Just like hepatitis C virus. A useful model for the study of immune response to chronic infection. @ucph.bsky.social authors.elsevier.com/c/1l7pUcOnAY...
May 21, 2025 at 6:08 AM
Modeling liver cancer caused by chronic hepacivirus infection. Great collab with Rice Lab
@rockefeller.edu
heavy lift by Mariana Batista #HCV #HCC #livercancer #cancer #chronicinfection
doi.org/10.1016/j.jh...
March 19, 2026 at 1:53 PM
Delighted to give the first talk of my PhD at the UK Hepacivirus and Flavivirus Meeting over the weekend, where I talked about using ML to understand arbovirus evolution 🦟!
Thank you to the organising committee and in particular my supervisors @maringerlab.bsky.social & @grovearmada.bsky.social
May 22, 2025 at 6:20 PM
Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection https://www.biorxiv.org/content/10.1101/2025.11.25.690605v1
November 26, 2025 at 8:16 PM
Conference, viruses and a great hiking!
A nice time in Lake District this weekend at the 21st UK Hepacivirus and Flavivirus meeting 🦠
May 20, 2025 at 6:42 AM
Katelyn Elizabeth Raney-Plourde will present “Characterization of Antibody Response to Equine Hepacivirus E2 Glycoprotein” (3:00-3:15 PM in 524b)
July 15, 2025 at 5:42 PM
Identification of claudin-3 as an entry factor for rat hepacivirus https://www.biorxiv.org/content/10.1101/2025.02.27.640490v1
February 28, 2025 at 3:21 AM
Discoveries unveil that while Hepatitis C virus (HCV) uses 5' FAD caps on RNAs, Norway rat hepacivirus 1 employs 5' NAD caps, showing evolutionary divergence in hepaciviruses. PMID:42373660, Nat Commun 2026, @NatureComms https://doi.org/10.1038/s41467-026-74886-0 #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Discovery of 5’ NAD capped viral RNAs reveals evolutionary divergent 5’ metabolite capping across hepaciviruses | Nature Communications
Hepatitis C virus (HCV), an important pathogen and prototype hepacivirus, 5’ caps its RNA with flavin adenine dinucleotide (FAD); no other 5’ metabolite capped viral RNAs have been identified. Here, we establish NADzymeID, allowing specific identification of 5’ nicotinamide adenine dinucleotide (NAD). Using NADzymeID, we find that Norway rat hepacivirus 1 (NrHV-1) and related hepaciviruses use 5’ NAD capping, whereas the closest relatives of HCV use 5’ FAD, thereby revealing evolutionary divergence of 5’ capping. NrHV-1 replication is attenuated in absence of NAD, and NrHV-1 is cleared more rapidly in mice with reduced intrahepatic NAD levels. As observed for 5’ FAD, 5’ NAD protects viral RNA from RIG-I mediated innate immune sensing. Thus, despite evolutionary divergence, metabolite capping generally confers evasion of innate immune responses. These represent the first examples of 5’ NAD capping for viruses, providing tools also to investigate the elusive function of cellular 5’ metab
doi.org
September 29, 2026 at 4:00 PM
In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirus
journals.plos.org/plospathogen...
In vivo and in vitro recombinant systems of a novel variant demonstrate cross-reactive neutralization for the HCV model virus, Norway rat hepacivirus
Author summary Vaccine development for hepatitis C virus (HCV) is currently impeded by the lack of suitable animal models. To address this, the Norway rat hepacivirus 1 (NrHV), a virus relatively clos...
journals.plos.org
September 29, 2025 at 3:07 PM
One for the hepaci fans. We found a cool new hepacivirus (along with some other things) in kiwi with dermatitis meridian.allenpress.com/jwd/article/...
A Metagenomic Investigation into Apteryx rowi Dermatosis Identifies Multiple Novel Viruses and a Highly Abundant Nematode
Abstract. Sporadic cases of dermatosis have been reported in wild Ōkārito Rowi (Apteryx rowi), a species of brown kiwi, for over a decade. The disease exhibits distinctive features, including lesions,...
meridian.allenpress.com
March 30, 2025 at 10:31 PM
A preprint using: pSpCas9(BB)-2A-Puro (RRID:Addgene_48139) from #Addgene was published.

SciScore made a table with this resource, see “Automated Services” module (download as csv, xml or #jats) #methodsmatter #RRID
Identification of claudin-3 as an entry factor for rat hepacivirus
www.biorxiv.org
March 2, 2025 at 1:01 PM
We started off collating and curating all Flaviviridae genomes, then built RdRp trees (225 in total), forming our study's backbone. We find that the Flaviviridae can be broken up into three clades: 1) LGF & Pestivirus, 2) Orthoflavivirus-Jingmenvirus, and 3) Pegivirus-Hepacivirus
February 7, 2024 at 10:54 AM
And I guess for Science’s sake that there’s capacity and support to continue unfundable projects in some way. Relying on continued fascination with a topic. If we found a zoonotic hepacivirus then this might change…
September 24, 2026 at 8:21 AM
Love hepaciviruses and flaviviruses? Want a relaxed, friendly conference with great science and great scenery?

HCV-FLAVI-UK 2026
📍 Rydal Hall, Lake District
📅 14–16 May

Registration open — closes 17 March
🔗 www.flaviviridae.uk

Please reshare 🦠

#Virology #Flavivirus #HCV
The UK Hepacivirus and Flavivirus Meeting
www.flaviviridae.uk
February 9, 2026 at 5:03 PM
American rabbits and hares face rabbit haemorrhagic disease virus 2, but little is known about their natural viromes. Using meta-transcriptomics, researchers explored the pathogens in these lagomorphs, unveiling three new viruses: two likely from insects and a novel hepacivirus related to a rat v...
Identification of novel hepaciviruses and Sylvilagus-associated viruses via metatranscriptomics in North American lagomorphs.
Published in Virus evolution
doi.org
July 21, 2025 at 7:00 PM
So what does this Treg-rich microenvironment do? We teamed up with the Billerbeck lab using the NrHV model (HCV-like hepacivirus). Neonates showed delayed viral clearance. Treg depletion accelerated clearance - strong evidence that this regulatory setpoint shapes antiviral control. (8/10)
January 15, 2026 at 9:12 AM
Molecular prevalence, genomic characterization, and zoonotic potential of novel paramyxovirus and hepacivirus in Alexandromys fortis, Republic of Korea

📰 Veterinary research

#Zoonoses #OneHealth #InfectiousDiseases #PublicHealth

🔗 https://doi.org/10.1186/s13567-026-01777-z
Molecular prevalence, genomic characterization, and zoonotic potential of novel paramyxovirus and hepacivirus in Alexandromys fortis, Republic of Korea
Rodents are substantial reservoirs of zoonotic viruses with regular human exposure restricted to a limited number of species. Numerous rodent species have been shown to harbor emerging viruses, inc...
link.springer.com
May 31, 2026 at 6:56 PM
Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection PLOSPathogens
Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection
by Yasunori Akaike, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Yoshiharu Matsuura, Kohji Moriishi The lack of immuno-competent animal models of hepatitis C virus (HCV) infection has been an obstacle to vaccine development and research on immune responses. Hepacivirus ratti (Norway rat hepacivirus-1: NRHV1) is a virus closely related to HCV that specifically infects the liver and induces hepatocellular carcinoma in rats, making it a promising surrogate model for HCV. NRHV1 expressing a reporter gene serves as a powerful tool for analyzing the in vivo dynamics and pathogenicity mechanisms of NRHV1. In this study, we developed a reporter NRHV1 capable of infection and replication in both immunodeficient mice and cultured cells and established a platform for generating diverse reporter viruses. A reporter virus containing the HiBiT gene in the coding region of NS5A domain III was constructed using circular polymerase extension reaction (CPER). Infection with this reporter virus led to HiBiT activity in infected cells and the activity was correlated with the amount of intracellular viral RNA. In addition, this reporter virus established persistent infection in NOD-SCID mice and led to the generation of HiBiT activity in the livers of infected mice, although loss of the HiBiT gene was observed in some mice. Furthermore, reporter virus recovered from infected mice could infect and generate HiBiT activity in cultured cells. These results demonstrate that the reporter virus can infect hepatocytes in vivo and in vitro. This platform provides a versatile tool for in vitro quantitative antiviral screening and for exploring viral infection dynamics in vivo, although further studies will be required to improve the long-term stability of the HiBiT reporter.
dlvr.it
April 12, 2026 at 12:12 AM
Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection PLOSPathogens
Generation of a HiBiT-expressing recombinant rat hepacivirus supporting both in vivo and in vitro infection
by Yasunori Akaike, Tomohisa Tanaka, Hirotake Kasai, Atsuya Yamashita, Yoshiharu Matsuura, Kohji Moriishi The lack of immuno-competent animal models of hepatitis C virus (HCV) infection has been an obstacle to vaccine development and research on immune responses. Hepacivirus ratti (Norway rat hepacivirus-1: NRHV1) is a virus closely related to HCV that specifically infects the liver and induces hepatocellular carcinoma in rats, making it a promising surrogate model for HCV. NRHV1 expressing a reporter gene serves as a powerful tool for analyzing the in vivo dynamics and pathogenicity mechanisms of NRHV1. In this study, we developed a reporter NRHV1 capable of infection and replication in both immunodeficient mice and cultured cells and established a platform for generating diverse reporter viruses. A reporter virus containing the HiBiT gene in the coding region of NS5A domain III was constructed using circular polymerase extension reaction (CPER). Infection with this reporter virus led to HiBiT activity in infected cells and the activity was correlated with the amount of intracellular viral RNA. In addition, this reporter virus established persistent infection in NOD-SCID mice and led to the generation of HiBiT activity in the livers of infected mice, although loss of the HiBiT gene was observed in some mice. Furthermore, reporter virus recovered from infected mice could infect and generate HiBiT activity in cultured cells. These results demonstrate that the reporter virus can infect hepatocytes in vivo and in vitro. This platform provides a versatile tool for in vitro quantitative antiviral screening and for exploring viral infection dynamics in vivo, although further studies will be required to improve the long-term stability of the HiBiT reporter.
dlvr.it
April 10, 2026 at 5:10 PM
Unwinding of an RNA duplex by the Orthoflavivirus NS3 helicase requires translocation beyond the displaced strand and is stimulated by the NS5 RdRp bioRxivpreprint
Unwinding of an RNA duplex by the Orthoflavivirus NS3 helicase requires translocation beyond the displaced strand and is stimulated by the NS5 RdRp
The NS3 helicases from the Flaviviridae family of viruses exhibit nucleotide-hydrolysis-dependent, nucleic-acid-unwinding activity. The RNA unwinding activity for NS3 helicases from the Orthoflavivirus genus has not been fully explored and contrasts with NS3 helicase from Hepatitis C virus (HCV) of the Hepacivirus genus, which has thus far served as the prototypical model enzyme from this family of viruses. To begin to understand the functional differences between flavivirus NS3 helicases, we first developed an expression and purification system for full-length untagged NS3 protein from West Nile virus (WNV) and Zika virus (ZIKV). Both enzymes exhibit RNA-stimulated ATPase activity and are dependent on the nucleoside triphosphatase active site of the enzyme. Unlike HCV NS3, orthoflavivirus NS3s do not efficiently pre-assemble on a 3-ssRNA-tailed dsRNA substrate in the absence of ATP-Mg which is a prerequisite for formation of a productive HCV NS3-RNA complex that can exhibit a rapid burst of RNA unwinding. Instead, to observe RNA unwinding by WNV and ZIKV NS3s, low Mg-ATP concentrations are required at a time coincident when NS3 encounters the RNA substrate. In addition, we find that orthoflavivirus NS3s require translocation beyond the displaced strand to completely unwind a dsRNA substrate. Last, we find that orthoflavivirus NS5 stimulates the ability of NS3 to unwind dsRNA. These results suggest that functional differences exist between the flavivirus NS3 helicases and illuminate that orthoflavivirus NS3s require a functional interaction with the NS5 protein for coordination of its activity, as it is believed these two proteins constitute the viral replicase.
dlvr.it
February 9, 2026 at 7:57 AM
Unwinding of an RNA duplex by the Orthoflavivirus NS3 helicase requires translocation beyond the displaced strand and is stimulated by the NS5 RdRp bioRxivpreprint
Unwinding of an RNA duplex by the Orthoflavivirus NS3 helicase requires translocation beyond the displaced strand and is stimulated by the NS5 RdRp
The NS3 helicases from the Flaviviridae family of viruses exhibit nucleotide-hydrolysis-dependent, nucleic-acid-unwinding activity. The RNA unwinding activity for NS3 helicases from the Orthoflavivirus genus has not been fully explored and contrasts with NS3 helicase from Hepatitis C virus (HCV) of the Hepacivirus genus, which has thus far served as the prototypical model enzyme from this family of viruses. To begin to understand the functional differences between flavivirus NS3 helicases, we first developed an expression and purification system for full-length untagged NS3 protein from West Nile virus (WNV) and Zika virus (ZIKV). Both enzymes exhibit RNA-stimulated ATPase activity and are dependent on the nucleoside triphosphatase active site of the enzyme. Unlike HCV NS3, orthoflavivirus NS3s do not efficiently pre-assemble on a 3-ssRNA-tailed dsRNA substrate in the absence of ATP-Mg which is a prerequisite for formation of a productive HCV NS3-RNA complex that can exhibit a rapid burst of RNA unwinding. Instead, to observe RNA unwinding by WNV and ZIKV NS3s, low Mg-ATP concentrations are required at a time coincident when NS3 encounters the RNA substrate. In addition, we find that orthoflavivirus NS3s require translocation beyond the displaced strand to completely unwind a dsRNA substrate. Last, we find that orthoflavivirus NS5 stimulates the ability of NS3 to unwind dsRNA. These results suggest that functional differences exist between the flavivirus NS3 helicases and illuminate that orthoflavivirus NS3s require a functional interaction with the NS5 protein for coordination of its activity, as it is believed these two proteins constitute the viral replicase.
dlvr.it
February 8, 2026 at 12:56 AM